Page last updated: 2024-09-05

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Inflammation

n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide has been researched along with Inflammation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdel-Wahab, O; Bradley, RK; Cho, H; Chow, A; Chowell, D; Cui, D; De Neef, E; Diaz, LA; Durham, BH; Elhanati, Y; Erickson, C; Gabel, AM; Ghosh, A; Gigoux, M; Greenbaum, B; Hogg, SJ; Jin, J; Knorr, DA; Liu, J; Lu, B; Lu, SX; Merghoub, T; Molina, H; Rhodes, MC; Rousseau, B; Sabio, E; Shah, H; Shen, Y; Singer, M; Taylor, RE; Thomas, JD; Wang, E; Wolchok, JD; Xie, A; Zamarin, D1

Other Studies

1 other study(ies) available for n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide and Inflammation

ArticleYear
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
    Cell, 2021, 07-22, Volume: 184, Issue:15

    Topics: Animals; Antigen Presentation; Antigens, Neoplasm; Cell Line, Tumor; Cell Proliferation; Epitopes; Ethylenediamines; Gene Expression Regulation, Neoplastic; Hematopoiesis; Histocompatibility Antigens Class I; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Inflammation; Mice, Inbred C57BL; Neoplasms; Peptides; Protein Isoforms; Pyrroles; RNA Splicing; Sulfonamides; T-Lymphocytes

2021